Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary
Sales Agreement Announcement: Lakeside Holding Limited has announced a Sales Agreement with Hupan Pharmaceutical and Sinopharm Holding Hubei for the delivery of critical medicines valued at approximately $1.5 million, effective from January 1, 2025.
Strategic Expansion: This agreement follows a recent partnership focused on essential medicine logistics, highlighting Hupan Pharmaceutical's growing role in China's pharmaceutical market and Lakeside's commitment to enhancing its cross-border logistics capabilities.
Discover Tomorrow's Bullish Stocks Today
Analyst Views on LSH
About LSH
About the author

Lakeside Holding files to sell 7.4M shares of common stock for holders
Lakeside Holding Stock Offering: Lakeside Holding (LSH) has filed to sell 7.4 million shares of common stock for its holders.
Recent Company Developments: The company has announced board resignations and appointments, as well as secured new distribution agreements with Kelun Pharmaceutical.

LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION
Securities Purchase Agreement: Lakeside Holding Limited has entered into a securities purchase agreement to sell up to $4.5 million in senior secured convertible promissory notes, with the first tranche generating approximately $930,000 in gross proceeds.
Company Overview: Lakeside is a U.S.-based supply chain solution provider focused on the Asia-Pacific market, operating through its subsidiaries American Bear Logistics and Hupan Pharmaceutical, enhancing its logistics capabilities in both general and pharmaceutical sectors.






